1. Home
  2. AUID vs CANF Comparison

AUID vs CANF Comparison

Compare AUID & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$0.31

Market Cap

7.3M

Sector

Technology

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$1.82

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AUID
CANF
Founded
2009
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
6.7M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
AUID
CANF
Price
$0.31
$1.82
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $7.50
AVG Volume (30 Days)
★ 387.3K
24.4K
Earning Date
11-11-2026
09-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 60.00
N/A
EPS
N/A
★ N/A
Revenue
★ $2,040,660.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 130.20
N/A
52 Week Low
$0.30
$0.17
52 Week High
$2.87
$10.40

Technical Indicators

Market Signals
Indicator
AUID
CANF
Relative Strength Index (RSI) 40.98 28.80
Support Level N/A $1.75
Resistance Level $0.59 $2.27
Average True Range (ATR) 0.05 0.09
MACD 0.00 0.01
Stochastic Oscillator 7.97 11.79

Price Performance

Historical Comparison
AUID
CANF

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring enterprises - Know Who's Behind the Device, for every customer or employee login and transaction, through its easy-to-integrate, patented, biometric identity platform. authID powers biometric identity proofing, biometric authentication, and account recovery with a fast, accurate, user-friendly experience. With its PrivacyKey solution, authID provides accurate biometric authentication while storing no biometric data. authID's goal is to stop fraud at onboarding, blocks deepfakes, prevents account takeover, and eliminates password risks and costs, through the faster, and accurate user identity experience demanded by the digital ecosystem Its products are: IDX Mandate for Agentic AI, PrivacyKey, Identity Verification, and Biometric Authentication.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: